Access to Medicines | Medicines Law & Policy

Strong call for transparency on medicine prices, cost of R&D at...

Ellen 't Hoen - April 19, 2019

Humiragate: AbbVie’s desperate attempts to keep its monopoly

Ellen 't Hoen - March 27, 2019

Cystic Fibrosis Medicines Wars in Europe

Ellen 't Hoen - February 3, 2019

Cancer Drug Pricing on the World Health Organization’s Executive Board Agenda

Ellen 't Hoen - January 23, 2019

Time to put a stop to the abuse of orphan drug...

Ellen 't Hoen - January 9, 2019

2018 Round-up of Noteworthy Medicines Law and Policy Events

Ellen 't Hoen - December 26, 2018

New Database Documents the Power of TRIPS Flexibilities

Ellen 't Hoen - November 27, 2018

Dutch health insurance company Menzis takes AstraZeneca to court over patent...

Ellen 't Hoen - September 20, 2018

CJEU Ruling on Truvada recalls ‘evergreening’ goes against public health interests

Pascale Boulet - September 10, 2018

Will the European Court of Justice put a stop to the...

Pascale Boulet - May 8, 2018

12 3 Page 1 of 3